INVESTIGATION OF POLY (ADP-RIBOSE) POLYMERASE 1 (PARP1) AS A NOVEL THERAPEUTIC TARGET IN SMALL CELL LUNG CANCER (SCLC)

被引：0

作者：

Byers, Lauren A. ^{[1
]}

Nilsson, Monique ^{[1
]}

Fujimoto, Junya ^{[1
]}

Saintigny, Pierre ^{[1
]}

Wang, Jing ^{[1
]}

Diao, Lixia ^{[1
]}

Peyton, Michael ^{[2
]}

Fan, You-Hong ^{[1
]}

Giri, Uma ^{[1
]}

Weber, Stephanie ^{[2
]}

Duchemann, Boris ^{[1
]}

Girard, Luc ^{[2
]}

Coombes, Kevin ^{[1
]}

Weinstein, John ^{[1
]}

Minna, John D. ^{[2
]}

Wistuba, Ignacio ^{[1
]}

Heymach, John V. ^{[1
]}

机构：

[1] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA

[2] Univ Texas SW Med Ctr, Hamon Ctr Therapeut Oncol Res, Dallas, TX 75390 USA

来源：

JOURNAL OF THORACIC ONCOLOGY | 2011年 / 6卷 / 06期

关键词：

SCLC; PARP1; Large cell neuroendocrine;

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：S1530 / S1531

页数：2

共 50 条

[31] POLY (ADP-RIBOSE) POLYMERASE 1 (PARP1) PROMOTES THE RELEASE OF HMGB1 INCREASING INTESTINAL INFLAMMATION
Mancuso, Anna Barbara
Vitali, Roberta
Palone, Francesca
Fiaschini, Noemi
Colantoni, Eleonora
Cucchiara, Salvatore
Isoldi, Sara
Rossetti, Danilo
Stronati, Laura
GASTROENTEROLOGY, 2020, 158 (06) : S49 - S49
[32] Role of Poly(ADP-ribose) polymerase 1 (PARP-1) in cardiovascular diseases:: The therapeutic potential of PARP inhibitors
Pacher, Pal
Szabo, Csaba
CARDIOVASCULAR DRUG REVIEWS, 2007, 25 (03): : 235 - 260
[33] Roles of poly (ADP-ribose) polymerase (PARP1) cleavage in the ovaries of fetal, neonatal, and adult pigs
Wei, Quanwei
Ding, Wei
Shi, Fangxiong
REPRODUCTION, 2013, 146 (06) : 593 - 602
[34] PARP1 is a TRF2-associated poly(ADP-ribose)polymerase and protects eroded telomere
Gomez, M
Wu, J
Schreiber, V
Dunlap, J
Dantzer, F
Wang, YS
Liu, Y
MOLECULAR BIOLOGY OF THE CELL, 2006, 17 (04) : 1686 - 1696
[35] Beyond PARP1: The Potential of Other Members of the Poly (ADP-Ribose) Polymerase Family in DNA Repair and Cancer Therapeutics
Richard, Iain A.
Burgess, Joshua T.
O'Byrne, Kenneth J.
Bolderson, Emma
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2022, 9
[36] Poly(ADP-ribose) polymerase 1 is a novel target to promote axonal regeneration
Brochier, Camille
Jones, James I.
Willis, Dianna E.
Langley, Brett
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2015, 112 (49) : 15220 - 15225
[37] Poly(ADP-ribose) polymerase (PARP) inhibitors and ovarian cancer
Liu, Chia-Hao
Chang, Yi
Wang, Peng-Hui
TAIWANESE JOURNAL OF OBSTETRICS & GYNECOLOGY, 2017, 56 (05): : 713 - 714
[38] Hyperactivation of Poly (ADP-ribose) Polymerase 1 (PARP1) Triggers Global Metabolic Alterations in a Cellular Model of Glioblastoma
Wilk, A. M.
Johnston, B.
Fouquerel, E.
Cooper, S. J.
Sobol, R. W.
ENVIRONMENTAL AND MOLECULAR MUTAGENESIS, 2015, 56 : S61 - S61
[39] Transcriptional Reprogramming and Resistance to Colonic Mucosal Injury in Poly(ADP-ribose) Polymerase 1 (PARP1)-deficient Mice
Larmonier, Claire B.
Shehab, Kareem W.
Laubitz, Daniel
Jamwal, Deepa R.
Ghishan, Fayez K.
Kiela, Pawel R.
JOURNAL OF BIOLOGICAL CHEMISTRY, 2016, 291 (17) : 8918 - 8930
[40] Targeting BRCA1 Localization to Augment Tumor Cell Susceptibility to Poly (ADP-ribose) Polymerase-1 (PARP1) Inhibition
Yang, S.
Nowsheen, S.
Xia, F.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2010, 78 (03): : S89 - S89

← 1 2 3 4 5 →